TAKING A CLOSER LOOK
INTEGRATIVE SPECIALIZATIONS IN TODAY'S PRACTICE
27-28 September 2018
The Garden Ballroom, Edsa Shangrila Hotel
Mandaluyong City, Metro Manila
Annual Medical Congress 2018
JACK CHI-LIANG, WEI ( 魏吉良)
Dr Jack Wei, is an expert in the field of natural Peroxisome Proliferator Activated Receptor agonists and algae. With numerous published scientific work in the area of cell microbiology and genetics, Mr Wei is a sought out speaker on the topic.
His many years of experience heading both medical technology and agricultural companies makes him relatable, able to share scientific perspectives in a manner that is immediately understandable and applicable.
March 2005 - Sep.2005
The Program of Multi-Discipline Management of Technology /Intellectual Property , Technology Transfer, Investment Value.National Chenhchi University, Taiwan University of California system, Standford,
University of Washington, US
MASTER OF LIFE SCIENCE IN BOTANY
NATIONAL CHUNG SHING UNIVERSITY, TAIWAN
Thesis topic: Cloning and Analysis of the Gene Encoding UDP-glucose Pyrophosphorylase Involved in Synthesis Xanthan Gum in Xanthomonas campestris pv. campestris
BACHELOR OF SCIENCE IN MICROBIOLOGY, SOOCHOW UNIVERSITY, TAIWAN
Thesis topic: Setting-up of the analytical method and comparison of patience on fatty acid of toluene tolerance bacterium (甲苯耐受性細菌 酯肪酸分析⽅方法之建⽴立與耐性之⽐比較)
2007 to present
Professional Chlorella cultivation and production company in Taiwan.Supply unique Chlorella as health food supplement to whole the world. 2007~2010, International Business manager.
2010~present, Deputy General Manager
November 2005 to 2007
CHUIN SHIU ENTERPRISE CO LTD., MAIAOLI, TAIWAN (DAINTY DESIGN)
One of the biggest domestic cosmetic brand and manufacturer / owning above 200 channel stores and several foreign distributors, annual revenue of NT$ 2 billion, and over 500 employees.
Manager, General Manager Department
February 2003 to May 2005
GENMEDIKA BIOTECHNOLOGY CORP., TAIPEI, TAIWAN
Rapid diagnostic test kits R&D and manufacture/ supplier of biotech, medical and analytical research product
Deputy Manager, Business Department.
August 2000 to February 2004
BEAM International LTD., TAIPEI, TAIWAN
One of the largest distributor in clinical diagnostic/medical device field, annual revenue of NT$ 5 hundred million, and 80 employees
Special Assistant, General Manager Office
Sales/Business Development Specialist, Medical/Biotech Division
Sales/Business Development Specialist, Scientific Home Incorporation, Beam Group
August 1998 to July 2000
Bio-resource Collection & Research Center/
Food Industry Research & Development Institute, HsinChu, TAIWAN
Associate Research Fellow, Bio-resource Development Department, Taiwan Health food development by Biotechnology & Microbiology
Lin. X.-J., C.-L. Wei, Q.-Y. Wen, J.-Q Liao and W.-S. Zhu (1999). Erythritol-yield strain selection, improvement and fermentation. The Research Document of Food Industry Research & Development Institute NO. 88-1474.
Wen, Q.-Y., C.-L. Wei, J.-Q Liao , X.-J. Lin and W.-S. Zhu.(1999). The defined culture conditions of the erythritol-yield strain (conference poster). The 29th of Taiwan Association for Food Science and Technology.
Wei, C.-L., J.-Q Liao, Q.-Y. Wen, X.-J. Lin and W.-S. Zhu.(1999). Development of fermentation conditions from erythritol-yield strain. The 29th of Taiwan Association for Food Science and Technology (oral presentation)
*Wei, C.-L., N.-T. Lin, S.-F. Weng and Y.-H. Tseng. (1996). The gene encoding UDP-glucose pyrophosphorylase is required for the synthesis of xanthan gum in Xanthomonas campestris. Biochem. Biophys. Res. Commun. 226:607-612.
* Wei, C.-L., K.-T. Choy, N.-T. Lin, and Y.-H. Tseng. (1996). Increase of xanthan production by self-cloning of a 3.0-kb EcoRI-KpnI chromosomal fragment in Xanthomonas campestris. Biotechnol. Lett. 18:1301-1304.